USDA Emergency Commodity Assistance Program (ECAP)

Mar 24, 2025

The United States Department of Agriculture (USDA) is allocating up to $10 billion directly to agricultural producers through the Emergency Commodity Assistance Program (ECAP) for the 2024 crop year. This funding aims to support growers facing multiple years of low crop prices combined with high input costs.

The economic relief payment, approved under the American Relief Act, is determined by the number of planted and prevented-planted crop acres in 2024 for eligible commodities. Corn will receive a payment rate of $42.91 per acre, while wheat will be paid at a rate of $30.69 per acre. A complete list of eligible commodities is available here.

Growers can use the payment calculator to estimate their payment amount for eligible commodities and acreage. Payments will be distributed as applications are approved, with initial payments calculated at 85% to ensure the total program payments stay within available funding. If there are remaining funds, the FSA may issue a second payment.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.